| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 183.265.484 $ | 96,02 | 10.217.456 | ||||||
| Bayer Aktiengesellschaft | BAYER AG | EC | DE000BAY0017 | Long | Modellwert (Stufe 2) | 9.184.987 $ | 4,81 | 165.508 | |
| Twist Bioscience Corp | TWIST BIOSCIENCE CORP | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 9.149.232 $ | 4,79 | 99.937 | |
| REVOLUTION MEDICINES, INC. | REVOLUTION MEDICINES INC | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 8.692.391 $ | 4,55 | 46.352 | |
| REGENERON PHARMACEUTICALS, INC. | REGENERON PHARMACEUTICALS INC | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 8.302.753 $ | 4,35 | 10.887 | |
| GENMAB A/S | GENMAB A S | EC | DK0010272202 | Long | Modellwert (Stufe 2) | 8.079.336 $ | 4,23 | 28.069 | |
| INCYTE CORPORATION | INCYTE CORPORATION | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 8.075.966 $ | 4,23 | 67.570 | |
| MODERNA, INC. | MODERNA INC | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 7.993.798 $ | 4,19 | 145.819 | |
| Takeda Pharmaceutical Company Limited | TAKEDA PHARMACEUTICAL CO LTD | EC | JP3463000004 | Long | Modellwert (Stufe 2) | 7.728.949 $ | 4,05 | 225.100 | |
| MERCK & CO., INC. | MERCK CO INC | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 7.456.554 $ | 3,91 | 57.270 | |
| VERTEX PHARMACEUTICALS INCORPORATED | VERTEX PHARMACEUTICALS INC | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 7.385.985 $ | 3,87 | 15.481 | |
| Roche Holding AG | ROCHE HOLDING AG | EC | CH1499059983 | Long | Modellwert (Stufe 2) | 7.341.404 $ | 3,85 | 16.796 | |
| IPSEN SA | IPSEN SA | EC | FR0010259150 | Long | Modellwert (Stufe 2) | 7.328.654 $ | 3,84 | 37.928 | |
| EXELIXIS, INC. | EXELIXIS INC | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 6.961.513 $ | 3,65 | 131.275 | |
| GSK PLC | GSK PLC | EC | GB00BN7SWP63 | Long | Modellwert (Stufe 2) | 6.934.182 $ | 3,63 | 266.670 | |
| SANOFI SA | SANOFI | EC | FR0000120578 | Long | Modellwert (Stufe 2) | 6.612.342 $ | 3,46 | 76.788 | |
| IDEAYA Biosciences Inc | IDEAYA BIOSCIENCES INC | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 6.407.147 $ | 3,36 | 180.483 | |
| Immunitybio Inc | IMMUNITYBIO INC | EC | 45256X103 | Long | Börsenkurs (Stufe 1) | 5.859.202 $ | 3,07 | 817.183 | |
| ARCUS BIOSCIENCES, INC. | ARCUS BIOSCIENCES INC | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 5.123.899 $ | 2,68 | 181.763 | |
| CARIS LIFE SCIENCES, INC. | CARIS LIFE SCIENCES INC | EC | 142152107 | Long | Börsenkurs (Stufe 1) | 4.170.335 $ | 2,18 | 266.135 | |
| ONO PHARMACEUTICAL CO., LTD. | ONO PHARMACEUTICAL CO LTD | EC | JP3197600004 | Long | Modellwert (Stufe 2) | 3.654.051 $ | 1,91 | 244.500 | |
| Iovance Biotherapeutics Inc | IOVANCE BIOTHERAPEUTICS INC | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 3.426.248 $ | 1,80 | 841.830 | |
| NUVATION BIO INC. | NUVATION BIO INC | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 3.394.659 $ | 1,78 | 536.281 | |
| CRISPR Therapeutics AG | CRISPR THERAPEUTICS AG | EC | H17182108 | Long | Börsenkurs (Stufe 1) | 2.987.234 $ | 1,57 | 62.247 | |
| ABCELLERA BIOLOGICS INC. | ABCELLERA BIOLOGICS INC | EC | 00288U106 | Long | Börsenkurs (Stufe 1) | 2.906.019 $ | 1,52 | 508.935 | |
| Vir Biotechnology Inc | VIR BIOTECHNOLOGY INC | EC | 92764N102 | Long | Börsenkurs (Stufe 1) | 2.505.035 $ | 1,31 | 289.265 | |
| NOVAVAX, INC. | NOVAVAX INC | EC | 670002401 | Long | Börsenkurs (Stufe 1) | 2.486.187 $ | 1,30 | 339.643 | |
| Janux Therapeutics Inc | JANUX THERAPEUTICS INC | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 1.883.598 $ | 0,99 | 124.166 | |
| Sunshine Lake Pharma Co Ltd | SUNSHINE LAKE PHARMA CO LTD | EC | Y8243F109 | Long | Börsenkurs (Stufe 1) | 1.874.392 $ | 0,98 | 351.500 | |
| Corvus Pharmaceuticals Inc | CORVUS PHARMACEUTICALS INC | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 1.817.933 $ | 0,95 | 137.099 | |
| Personalis Inc | PERSONALIS INC | EC | 71535D106 | Long | Börsenkurs (Stufe 1) | 1.702.504 $ | 0,89 | 134.479 | |
| Kura Oncology Inc | KURA ONCOLOGY INC | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 1.679.896 $ | 0,88 | 186.448 | |
| GenFleet Therapeutics (Shanghai) Inc | GENFLEET THERAPEUTICS SHANGHAI INC | EC | Y2S2YD109 | Long | Modellwert (Stufe 2) | 1.480.868 $ | 0,78 | 419.200 | |
| RIGEL PHARMACEUTICALS, INC. | RIGEL PHARMACEUTICALS INC | EC | 766559702 | Long | Börsenkurs (Stufe 1) | 1.428.486 $ | 0,75 | 38.807 | |
| CytomX Therapeutics Inc | CYTOMX THERAPEUTICS INC | EC | 23284F105 | Long | Börsenkurs (Stufe 1) | 1.165.315 $ | 0,61 | 375.908 | |
| VERASTEM, INC. | VERASTEM INC | EC | 92337C203 | Long | Börsenkurs (Stufe 1) | 1.036.570 $ | 0,54 | 178.719 | |
| Alvotech SA | ALVOTECH SA | EC | L01800108 | Long | Börsenkurs (Stufe 1) | 1.008.988 $ | 0,53 | 244.900 | |
| Design Therapeutics Inc | DESIGN THERAPEUTICS INC | EC | 25056L103 | Long | Börsenkurs (Stufe 1) | 996.421 $ | 0,52 | 81.808 | |
| Xencor Inc | XENCOR INC | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 983.641 $ | 0,52 | 48.671 | |
| INTELLIA THERAPEUTICS, INC. | INTELLIA THERAPEUTICS INC | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 981.364 $ | 0,51 | 91.888 | |
| Shanghai Henlius Biotech Inc | SHANGHAI HENLIUS BIOTECH INC | EC | CNE100003N76 | Long | Modellwert (Stufe 2) | 964.127 $ | 0,51 | 135.900 | |
| OCUGEN, INC. | OCUGEN INC | EC | 67577C105 | Long | Börsenkurs (Stufe 1) | 890.253 $ | 0,47 | 723.783 | |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | PACIFIC BIOSCIENCES OF CALIFORNIA INC | EC | 69404D108 | Long | Börsenkurs (Stufe 1) | 870.867 $ | 0,46 | 622.048 | |
| VALNEVA SE | VALNEVA SE | EC | FR0004056851 | Long | Modellwert (Stufe 2) | 866.333 $ | 0,45 | 349.239 | |
| Ginkgo Bioworks Holdings Inc | GINKGO BIOWORKS HOLDINGS INC | EC | 37611X209 | Long | Börsenkurs (Stufe 1) | 819.711 $ | 0,43 | 101.324 | |
| AbClon Inc. | ABCLON INC | EC | Y0R0KQ104 | Long | Modellwert (Stufe 2) | 469.839 $ | 0,25 | 34.319 | |
| Prime Medicine, Inc | PRIME MEDICINE INC | EC | 74168J101 | Long | Börsenkurs (Stufe 1) | 191.202 $ | 0,10 | 65.480 | |
| ARCELLX INC CVR | ARCELLX INC CVR | EC | 039CVR014 | Long | Modellwert (Stufe 2) | 5.114 $ | 0,00 | 73.059 | |
| OMNIAB INC | OMNIAB INC | EC | 68218J301 | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 38.996 | |
| Gesamt | 183.265.484 $ | 96,02 | 10.217.456 |